Topics

Partnership with China prompts change in care for high-risk type of leukemia

19:00 EST 15 Jan 2020 | AAAS

(St. Jude Children's Research Hospital) Findings from a collaborative clinical trial have generated key insights into how targeted therapy should be used to treat leukemia driven by the Philadelphia chromosome.

Original Article: Partnership with China prompts change in care for high-risk type of leukemia

NEXT ARTICLE

More From BioPortfolio on "Partnership with China prompts change in care for high-risk type of leukemia"

Quick Search

Relevant Topics

Pediatrics
Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...